Klinikum Oldenburg
Oldenburg, Germany
Hospital in Oldenburg, Lower Saxony
Rahel-Straus-Straße 10, 26133 Oldenburg
About Klinikum Oldenburg
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
German CLL Study Group
6
University of Ulm
6
German High-Grade Non-Hodgkin's Lymphoma Study Group
5
Goethe University
5
Abbott Medical Devices
4
Boston Scientific Corporation
4
Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany
4
Boehringer Ingelheim
2
Celgene
2
Daiichi Sankyo, Inc.
2
Klinikum Oldenburg gGmbH
2
Clinical Trials at Klinikum Oldenburg
During the past decade, Klinikum Oldenburg conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 12 clinical trials were completed, i.e. on
average, 35.3% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 4 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-10-01
2013-04-01
Completed
460
Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
1997-05-01
2002-02-01
Completed
Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia
1997-07-01
Unknown status
1,000
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)
2004-11-01
Completed
135
Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon
2003-11-01
2005-09-01
Unknown status
600
Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
2001-05-01
2009-09-01
Completed
120
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klinikum Oldenburg" #1 sponsor was "German CLL Study Group" with 6 trials, followed by "University of Ulm" with 6 trials
sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials sponsored, "Goethe University" with 5 trials sponsored and "Abbott Medical Devices"
with 5 trials sponsored. Other sponsors include 66 different institutions and
companies that sponsored additional 61 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Oldenburg"
#1 collaborator was "Deutsche Kinderkrebsstiftung" with 4 trials as a collaborator, "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 3 trials as a collaborator, "Arbeitsgemeinschaft Pädiatrische Radioonkologie (APRO)" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator and "Cancer Trials Ireland" with 2 trials as a collaborator. Other collaborators include 63 different institutions and companies that were
collaborators in the rest 66 trials.
Clinical Trials Conditions at Klinikum Oldenburg
According to Clinical.Site data, the most researched conditions in "Klinikum Oldenburg" are
"Lymphoma" (8 trials), "Acute Myeloid Leukemia" (6 trials), "Heart Failure" (5 trials), "Leukemia" (5 trials) and "Chronic Lymphocytic Leukemia" (4 trials). Many other conditions were trialed in "Klinikum Oldenburg" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Oldenburg
Most popular intervention types in "Klinikum Oldenburg" are "Drug" (61 trials), "Biological" (20 trials), "Device" (15 trials), "Radiation" (15 trials) and "Procedure" (14 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (14 trials), "radiation therapy" (12 trials), "doxorubicin hydrochloride" (11 trials), "vincristine sulfate" (11 trials) and "filgrastim" (9 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Oldenburg
The vast majority of trials in "Klinikum Oldenburg" are
91 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Klinikum Oldenburg
Currently, there are NaN active trials in "Klinikum Oldenburg".
undefined are not yet recruiting,
20 are recruiting,
12 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 50 completed trials in Klinikum Oldenburg,
1 suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Oldenburg, 2 "Phase 1"
clinical trials were conducted, 24 "Phase 2" clinical
trials and 39 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 17 trials that are defined as “Not Applicable".
Departments of Klinikum Oldenburg
Klinikum Oldenburg has several departments that took part in Clinical trials: "Medizinisches Versorgungszentrum am Klinikum Oldenburg GmbH" - 2 trials, "Klinikum Oldenburg AöR, Zentrum für Kinder- und Jugendmedizin, Abt. Hämatologie / Onkologie" - 2 trials
Departments List